CYCLOSPORINE AND ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY THERAPY SUPPRESS ACCELERATED REJECTION OF RAT CARDIAC ALLOGRAFTS THROUGH DIFFERENT EFFECTOR MECHANISMS